| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $203.7M | +340.9% |
| Cost of Revenue | $155.7M | +289.1% |
| Gross Profit | $48.0M | +675.7% |
| R&D Expense | $14.6M | -43.7% |
| SG&A Expense | $81.2M | +28.9% |
| Operating Income | -$74.4M | +42.8% |
| Pre-tax Income | -$95.9M | +29.4% |
| Income Tax | $7.8M | — |
| Net Income | -$103.6M | +23.7% |
| EPS (Basic) | -$0.65 | +28.6% |
| EPS (Diluted) | -$0.65 | +28.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $58.3M | +115.1% |
| Short-term Investments | $325K | -88.9% |
| Accounts Receivable | $25.9M | +78.1% |
| Inventory | $139K | +29.9% |
| Current Assets | $121.1M | +75.7% |
| Total Assets | $312.9M | +70.1% |
| Current Liabilities | $165.0M | +201.9% |
| Long-term Debt |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.6M | +89.9% |
| Capital Expenditures | $41.1M | -30.2% |
| Investing Cash Flow | -$44.6M | +24.1% |
| Financing Cash Flow | $123.0M | — |
| Free Cash Flow | -$46.7M | +59.3% |
| $38.0M |
| — |
| Total Liabilities | $224.3M | +289.1% |
| Stockholders' Equity | $67.5M | -46.6% |